Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Dr Reddys Labo Dr Reddys Laboratories Ltd. | BSE 1244.95 10.40 (0.84%) | NSE 1246.00 11.10 (0.90%) | Trade | Add

BSE Live

Nov 14, 16:01

1244.95 10.40 (0.84%)

Volume

AVERAGE VOLUME

5-Day

31,277

10-Day

47,415

30-Day

228,999

22,038

Prev. Close

1234.55
Open Price

1241.30

Bid Price (Qty.)
1244.95 (18)
Offer Price (Qty.)
1244.95 (2)

NSE Live

Nov 14, 15:58

1246.00 11.10 (0.90%)

Volume

AVERAGE VOLUME

5-Day

1,601,711

10-Day

1,745,827

30-Day

2,048,544

827,643

Prev. Close

1234.90
Open Price

1235.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	17,460.00	15,385.10	14,202.80	14,080.90	15,470.80
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	17,460.00	15,385.10	14,202.80	14,080.90	15,470.80
Total Operating Revenues	17,517.00	15,448.20	14,281.00	14,196.10	15,568.30
Other Income	620.60	337.50	155.20	171.50	295.00
Total Revenue	18,137.60	15,785.70	14,436.20	14,367.60	15,863.30
EXPENSES
Cost Of Materials Consumed	2,984.80	2,889.40	2,630.90	2,444.60	2,679.90
Purchase Of Stock-In Trade	2,545.90	1,880.80	1,450.10	1,375.20	1,174.30
Operating And Direct Expenses	0.00	0.00	0.00	0.00	242.30
Changes In Inventories Of FGWIP And Stock In Trade	23.70	-275.40	-41.50	-123.30	-95.70
Employee Benefit Expenses	3,380.20	3,356.20	3,214.90	3,106.80	3,117.40
Finance Costs	98.30	88.90	78.80	63.40	82.60
Depreciation And Amortisation Expenses	1,163.10	1,134.80	1,077.20	1,026.60	938.90
Other Expenses	4,435.30	4,407.40	4,675.40	4,920.60	4,864.80
Total Expenses	16,308.00	13,493.70	13,085.80	12,813.90	13,004.50
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,829.60	2,292.00	1,350.40	1,553.70	2,858.80
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	1,829.60	2,292.00	1,350.40	1,553.70	2,858.80
Tax Expenses-Continued Operations
Current Tax	661.60	470.70	175.30	309.60	743.20
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-801.90	-84.90	262.70	-13.10	7.90
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	-140.30	385.80	438.00	296.50	751.10
Profit/Loss After Tax And Before ExtraOrdinary Items	1,969.90	1,906.20	912.40	1,257.20	2,107.70
Profit/Loss From Continuing Operations	1,969.90	1,906.20	912.40	1,257.20	2,107.70
Profit/Loss For The Period	1,969.90	1,906.20	912.40	1,257.20	2,107.70
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit/Loss After MI And Associates	2,026.00	1,950.00	946.80	1,292.10	2,130.60
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	122.00	118.00	57.00	78.00	125.00
Diluted EPS (Rs.)	122.00	117.00	57.00	77.00	125.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	391.60	332.00	399.20	339.00	410.60
Tax On Dividend	0.00	68.20	0.00	0.00	0.00